Sun Pharma walk-in on 18th & 19th May 2024 ITI, Diploma, Bsc, Msc, B pharmacy, M pharmacy for manufacturing ( Parenteral) / QMS production ( Parenteral) / QA/QC/ microbiology ( QA & QC) ( Parenteral)
Sun Pharmaceutical Industries Limited (d/b/a Sun Pharma) is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynecology, respiratory, oncology, dental and nutritionals.
Sun Pharmaceutical Industries Ltd. was established by Dilip Shanghvi in 1983 in Vapi, Gujarat, with five psychiatry products and a two-person marketing team. Today it is ranked number one in share of prescriptions with 12 classes of doctors in India and a market leader in Psychiatry, Neurology, Cardiology, Orthopaedics, Gastroenterology, Nephrology, Diabetology, Dermatology, Urology, ENT, Chest and Consulting Physicians . The 2015 acquisition of Ranbaxy made Sun Pharma the largest pharma company in India, the largest Indian pharma company in the US, and the 5th largest specialty generic company globally. Around 70% of Sun Pharma’s revenue is generated from international markets.,. The US and India are the largest markets, accounting for over 60% of the company’s turnover;. Manufacturing is across 43 global locations in India, the US, Asia, Africa, Australia and Europe. In the United States, the company markets a large basket of generics, with a strong pipeline awaiting approval from the U.S. Food and Drug Administration (FDA). Sun Pharma was listed on the stock exchange in 1994 in an issue that was oversubscribed 55 times. The founding family continues to hold a majority stake in the company.In 2007, Sun Pharma demerged its innovative R&D arm, and listed it separately on the stock market as the Sun Pharma Advanced Research Company Ltd. (NSE: SPARC, BSE: 532872). In 2013, SPARC declared revenue of ₹873 million. SPARC focuses on new chemical entities (NCE) research and new drug delivery systems and offers an annual update of its pipeline (NDDS).
More about company
Vacancy details –
1. Department – manufacturing ( Parenteral)
Designation – Technician to executive
Experience – 2 to 8 year
Qualification – ITI/ diploma/ b pharma/ m pharm
2. Department – QMS production (Parenteral)
Designation – Sr officer to Sr executive
Experience – 4 to 10 years
Qualification – B pharmacy, M pharmacy
3. Department – Quality Control ( Parenteral/ OSD)
Designation- officer to executive
Experience – 2 to 8 year’s
Qualification – B pharm, M pharm, MSC
4. Department – Quality Assurance ( Parenteral)
Designation – officer to executive
Experience – 2 to 8 year’s
Qualification – B pharmacy, M pharmacy
5. Department – microbiology ( QA & QC) ( Parenteral)
Designation – officer to executive
Experience – 2 to 8 year’s
Qualification – BSC, MSC
Similar job’s
Job vacancy in Hetero walk-in on 19th May 2024
Sun Pharmaceutical Industries Ltd. was established by Dilip Shanghvi in 1983 in Vapi, Gujarat, with five psychiatry products and a two-person marketing team. Today it is ranked number one in share of prescriptions with 12 classes of doctors in India and a market leader in Psychiatry, Neurology, Cardiology, Orthopaedics, Gastroenterology, Nephrology, Diabetology, Dermatology, Urology, ENT, Chest and Consulting Physicians . The 2015 acquisition of Ranbaxy made Sun Pharma the largest pharma company in India, the largest Indian pharma company in the US, and the 5th largest specialty generic company globally. Around 70% of Sun Pharma’s revenue is generated from international markets.,. The US and India are the largest markets, accounting for over 60% of the company’s turnover;. Manufacturing is across 43 global locations in India, the US, Asia, Africa, Australia and Europe. In the United States, the company markets a large basket of generics, with a strong pipeline awaiting approval from the U.S. Food and Drug Administration (FDA). Sun Pharma was listed on the stock exchange in 1994 in an issue that was oversubscribed 55 times. The founding family continues to hold a majority stake in the company.In 2007, Sun Pharma demerged its innovative R&D arm, and listed it separately on the stock market as the Sun Pharma Advanced Research Company Ltd. (NSE: SPARC, BSE: 532872). In 2013, SPARC declared revenue of ₹873 million. SPARC focuses on new chemical entities (NCE) research and new drug delivery systems and offers an annual update of its pipeline (NDDS).
Important details –
Location – Sun Pharmaceutical industry Ltd, Halol plant ( Gujarat.)
Selection process – The selection will be on the basis of interview
Mode of interview – Face to face
Interview rounds of interview- HR
Walk-in interview details –
Date – 18th & 19th may 2024 ( Saturday and Sunday)
Time- 09:00 Am to 05:00 Pm
Venue – THE RED MAPLE, jhoomer ghat , rasalpura, Rau, Indore.
Note –
Candidates must bring 1 passport size photograph, PAN and Adhar card copy, educational certificate, 3 months salary slip, current company’s appointment letter, previous company’s releving letter & current CTC Details
For more job related updates joined WhatsApp group
https://chat.whatsapp.com/KCk1lRtEdlJEJYDBTQNc9i